New dialyser aims to cut blood thinner risks for kidney patients
NCT ID NCT06281028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two dialysis filters, SOLACEA-H and HYDROLINK-NVU, to see if SOLACEA-H can allow dialysis sessions with less or no blood thinner (heparin). The trial involves 20 adults who have been on dialysis for at least 3 months and are medically stable. Each participant will try both filters in sequence, gradually reducing blood thinner doses to find the minimum effective amount.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SOLACEA-H dialyser
What this could lead to
If successful, this dialyser could allow safer dialysis for patients at high risk of bleeding by reducing the need for blood thinners.
What could go wrong
This is a small, early-stage study with only 20 participants, so results may not apply to all dialysis patients. The device may not work as well as expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Privé La Louvière
Lille, 59800, France